Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 2021 Nov 25;100(2):161–167. doi: 10.2471/BLT.21.286317

COVID-19 response: effectiveness of weekly rapid risk assessments, Italy

Lutte contre la COVID-19: efficacité des évaluations hebdomadaires rapides des risques en Italie

Respuesta a la COVID-19: eficacia de las valoraciones semanales rápidas de los riesgos en Italia

الاستجابة لكوفيد 19: فعالية التقييمات الأسبوعية السريعة للمخاطر، إيطاليا

意大利新型冠状病毒肺炎应对措施:提高每周快速风险评估的效力

Меры реагирования на COVID-19: эффективность еженедельных оперативных оценок рисков, Италия

Flavia Riccardo a,, Giorgio Guzzetta b, Alberto Mateo Urdiales a, Martina Del Manso a, Xanthi D Andrianou a, Antonino Bella a, Patrizio Pezzotti a, Simona Carbone c, Tiziana De Vito c, Francesco Maraglino c, Vittorio Demicheli d, Claudio Dario e, Enrico Coscioni f, Giovanni Rezza c, Andrea Urbani c, Stefano Merler b, Silvio Brusaferro a; on behalf of the Italian COVID-19 monitoring group
PMCID: PMC8795855  PMID: 35125541

Abstract

Problem

After Italy’s first national restriction measures in 2020, a robust approach was needed to monitor the emerging epidemic of coronavirus disease 2019 (COVID-19) at subnational level and provide data to inform the strengthening or easing of epidemic control measures.

Approach

We adapted the European Centre for Disease Prevention and Control rapid risk assessment tool by including quantitative and qualitative indicators from existing national surveillance systems. We defined COVID-19 risk as a combination of the probability of uncontrolled transmission of severe acute respiratory syndrome coronavirus 2 and of an unsustainable impact of COVID-19 cases on hospital services, adjusted in relation to the health system’s resilience. The monitoring system was implemented with no additional cost in May 2020.

Local setting

The infectious diseases surveillance system in Italy uses consistent data collection methods across the country’s decentralized regions and autonomous provinces.

Relevant changes

Weekly risk assessments using this approach were sustainable in monitoring the epidemic at regional level from 4 May 2020 to 24 September 2021. The tool provided reliable assessments of when and where a rapid increase in demand for health-care services would occur if control or mitigation measures were not increased in the following 3 weeks.

Lessons learnt

Although the system worked well, framing the risk assessment tool in a legal decree hampered its flexibility, as indicators could not be changed without changing the law. The relative complexity of the tool, the impossibility of real-time validation and its use for the definition of restrictions posed communication challenges.

Introduction

In its first response to the emerging epidemic of coronavirus disease 2019 (COVID-19), the Italian government implemented national restriction measures with strict physical distancing and restrictions on public movements1 that were maintained from March to May 2020.2 Although followed by a rapid decrease in transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),1 the control measures had an adverse impact on the economy and society.3 To continue and further improve Italy’s preparedness and response capacity,4 we used an adapted version of the European Centre for Disease Prevention and Control (ECDC) rapid risk assessment tool5,6 to conduct weekly subnational assessments using data from public health intelligence.

Local setting

Italy’s health-care system is decentralized at regional level across 21 regions and autonomous provinces that largely differ in terms of size, population density and age structure as well as the financing and delivery of health care.7 The infectious diseases surveillance system uses consistent data collection methods across the country, with local health units collecting notifications from clinical services and investigating cases. Local health units transfer the data to regional and autonomous provincial authorities who verify and notify cases to the Ministry of Health and to the Italian national institute of health (Istituto Superiore di Sanità; the national centre for research, control and scientific advice on public health).

We designed the Italian COVID-19 risk assessment tool to provide reliable assessments in the different regional contexts. The risk assessments produced for each region and autonomous province were initially used to informally assist regional epidemic responses. Subsequently, in October 2020 the assessments were formally integrated as part of a flexible COVID-19 prevention and control response strategy for the autumn to winter 2020 season.4

From the beginning of November 2020,8 the Italian government implemented laws to define the need for strengthening or easing of regional interventions to control the epidemic, according to fixed parameters. Until May 2021, the weekly regional risk assessments became one of the parameters used to define the level of restrictions to be implemented. We have shown the effectiveness of this approach in a previous publication.9 Higher immunization coverage has decreased the impact of COVID-19 in terms of severe disease and death, and therefore the legal parameters used for mitigation of the pandemic were changed and risk assessments were no longer used. However, these assessments are still produced to date with the same method to monitor the epidemic and are published online.10

Approach

The aim of the risk assessment was to provide a weekly overall categorization of the risk of an uncontrolled and unsustainable SARS-CoV-2 outbreak in each of the 21 Italian regions and autonomous provinces. As per ECDC guidance, we defined risk as a combination of the probability of the health threat and its impact,5,6 described using consolidated risk categories (low, moderate, moderate with high probability of evolving to high, and high). We first assessed the probability and impact separately and then combined them to provide an overall risk, which we then adjusted in relation to an assessment of the health system’s resilience. This resilience element was an innovation not included in the original ECDC framework (see the authors’ data repository).11

The three components of the Italian risk assessment tool therefore were: (i) probability (evidence of increased transmission, as a proxy for increasing probability of uncontrolled SARS-CoV-2 transmission in a region or autonomous province); (ii) impact (evidence of unsustainable burden of COVID-19 cases on hospital services); and (iii) resilience (capacity of the public health system to withstand the burden of the pandemic and maintain its functions within the test, track and trace strategy).

We used three sets of quantitative indicators to assess these components (Table 1).12 The first set (data quality output indicators) defined the minimum levels of data completeness to allow the risk assessment; the second set (resilience output indicators) monitored the resilience of public health services in maintaining high levels of testing and contact tracing; the third set (probability and impact result indicators) monitored the probability of an uncontrolled spread of SARS-CoV-2 and of an unsustainable impact of COVID-19 on hospital services. For each indicator, we defined thresholds for alerts.

Table 1. Indicators used in the weekly COVID-19 epidemiological monitoring in regions and autonomous provinces, Italy, 2020–2021.

Indicator set Indicator Threshold Alert
Output indicator: data quality
Quality of data collected at the national level 1.1. Percentage of symptomatic cases with date of symptom onset reported ≥ 60% of cases with increasing trendsa < 60% of cases with increasing trends
1.2. Percentage of cases admitted to hospital (non-intensive care ward) with a date of admission or transfer reported
1.3. Percentage of cases admitted to hospital (intensive care unit) with a date of admission or transfer reported
1.4. Percentage of notified cases with the municipality of residence reported
Ability to test all cases in a timely manner 2.1. Percentage of swabs positive for SARS-CoV-2 infection per month, excluding swabs from screening and re-testing; overall and by setting (local, non-hospital, hospital emergency department, other) Decreasing percentage of positive swabs in hospital settings or emergency departments.
Stable or decreasing positive predictive value of tests
Increasing percentage of positive swabs in hospital settings or emergency departments.
Increasing positive predictive value of tests
2.2. Time between date of symptom onset and date of diagnosis of cases Weekly median gap ≤ 5 days Weekly median gap > 5 days
Output indicator: resilience
Adequacy of staff resources for contact tracing, isolation and quarantine 2.4. Number of staff dedicated to contact tracing in each local health unit (SARS-CoV-2)  1 professional staff member per 10 000 population < 1 professional staff member per 10 000 population
2.5. Number of staff dedicated in each unit to the activities for the collection and dispatch of clinical samples to the reference laboratories and monitoring of cases and close contacts placed in quarantine and in isolation, respectively
2.6. Number of confirmed cases in the region for which an epidemiological investigation has been carried out, with the search for close and total contacts of new confirmed cases Increasing number of investigated cases (final target 100%) Decreasing number of investigated cases (and lower than 90%)
Result indicator: probability and impact
Transmission stability
3.1. Number of cases diagnosed in the last 14 days, reported to the health ministry Weekly number of diagnosed cases stable or decreasing Increasing number of diagnosed cases in last 5 days
3.2. Value of transmissibility parameter based on data from the integrated central surveillance system. Two indicators are used, one based on date of symptom onset and one on date of hospitalizationb Regional net reproduction number (Rt) ≤ 1 in all regions and autonomous provincesc Rt > 1 or not assessed
3.4. Number of cases per date of diagnosis and date of symptom onset reported to the integrated central surveillance system per day Weekly number of reported cases stable or decreasing Increasing number of diagnosed cases in last 5 days
3.5. Number of new SARS-CoV-2 clusters, defined as two or more epidemiologically linked cases or an unexpected increase in the number of cases at a defined time and place No increase in the number of active clusters in the region (that is, clusters with cases still in isolation or quarantine, or new cases reported during the week) Increasing number of active clusters in the region (that is, clusters with cases still in isolation or quarantine, or new cases reported during the week)
3.6. Number of new cases not associated with known chains of transmission No explicit thresholds (qualitative assessment). If new outbreaks occur, the indicator can monitor the quality of contact tracing. Otherwise, the indicator could represent low transmission in which only sporadic cases are observed (considering undetected circulation in people with few symptoms) In the presence of outbreaks, the indicator requires an unplanned risk assessment defining whether there is sustained and widespread transmission that requires an escalation of epidemic control measures
Pressure on health-care system 3.8. Bed occupancy rate (percentage of available active hospital beds occupied by COVID-19 patients) in intensive care units for COVID-19 patients Bed occupancy, intensive care ≤ 30% Bed occupancy, intensive care > 30%
3.9. Bed occupancy rate (percentage of available active hospital beds occupied by COVID-19 patients) in non-intensive care wards for COVID-19 patients Bed occupancy, non-intensive care ≤ 40% Bed occupancy, non-intensive care > 40%

COVID-19: coronavirus disease 2019; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

a A value of at least 50% of cases with increasing trends was considered acceptable between 4 May and 25 May 2020.

b We have previously described the details of the calculations.1

c Net reproduction number is the transmissibility potential of the disease at a given time t of the disease.1

Notes: Cases refer to people with a laboratory confirmed diagnosis of SARS-CoV-2 infection reported to the national surveillance system. Translated with minor adaptations from the Decree of the Italian health ministry, 30 April 2020.12 The table only includes the non-optional indicators reported in the original ministerial decree as the other indicators were not relevant either because they were never compiled or because they just had a complementary role to the non-optional indicators here reported.

We assessed probability and impact separately using two dedicated algorithms each composed of three trigger questions requiring a yes/no answer. The first two questions in each algorithm were quantitative while the last question was qualitative.11 We compiled the quantitative questions using data from the described indicators (Table 1). To answer the qualitative questions, we activated the national event-based surveillance system13 and received weekly declarations from regional public health authorities. More specifically, regional authorities declared respectively if an uncontrolled SARS-CoV-2 transmission that could not be managed locally, or if new clusters of infection in vulnerable settings, were occurring.11 Once the assessment of the two algorithms for probability and impact was concluded, a first risk level was defined. We then looked at the resilience indicators. If we detected multiple alerts from the resilience indicators, we automatically scaled up the initial risk to the next risk level.

Relevant changes

Between 4 May 2020 and 24 September 2021, the Italian national institute of health performed 71 weekly risk assessments.10 Each assessment reported an updated classification of risk for each Italian region or autonomous province. As shown in Fig. 1, the risk assessments captured regional risk heterogeneities and were consistent overall with the national epidemic curve. In the data repository,11 graphs illustrate how the level of risk assigned was accurate in signalling when increases in the incidence of laboratory-confirmed severe and lethal infections were expected to occur within 3 weeks in the absence of additional control or mitigation measures.

Fig. 1.

Fig. 1

Epidemic curve and weekly risk assessment of the COVID-19 epidemic by region and autonomous province, Italy, 4 May 2020 to 27 September 2021

COVID-19: coronavirus disease 2019; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

Note: Cases refer to people with a laboratory confirmed diagnosis of SARS-CoV-2 infection notified to the national integrated case-based SARS-CoV-2 surveillance system. Regions include both regions and autonomous provinces of Italy.

In its early implementation, during low viral circulation in spring to summer 2020, the risk assessment system was very sensitive to localized clusters with limited cases, especially in smaller regions or autonomous provinces. The risk assessment therefore changed occasionally from low to moderate and then back to low as the clusters were contained. These findings, although consistent with the data, were misinterpreted as false alarms and led to some initial concern and distrust in the method among subject-matter experts. As the indicators could not be changed without changing the law, we solved these initial issues by clarifying concerns with public health officials without modifying the risk assessment tool.

Subsequently, the perceived complexity of the tool and the fact that risk assessments always addressed the previous week (too delayed) were criticized.14 The net reproduction number (Rt), which reflects the transmissibility of the disease, was also debated and for similar reasons. Even though the risk assessment tool only gave a very limited weight to Rt (Table 1), this controversy targeted its overall validity.

The weekly publication of the risk assessment findings10 became a contested topic in the media,14 increasingly so between November 2020 and May 2021, when higher risk was automatically associated by law with the enforcement of more severe restrictions to control the spread of the virus. Especially during the autumn to winter 2020 peak of COVID-19 cases, criticism of the assessment system expressed through the media increased, and numerous legal actions were started by representatives of different interest groups and organizations. However, to date, none of the legal actions have led to a re-evaluation of the published risks. Strategies that we adopted to improve public understanding included a weekly presentation of the risk assessments in a press conference and the production of releases and frequently asked questions pages on institutional websites.15 The assessment method became less debated after its automatic impact on decision-making stopped.

Lessons learnt

During a protracted outbreak, ensuring that control measures against the spread of disease are proportionate to the risk is important to limit an unwarranted impact on the economy and on the overall well-being of the population. Ensuring accountability and transparency to the general population is also needed.

The risk assessment system supported decision-making in Italy by effectively anticipating when the disease outbreak was expected to rapidly worsen, harnessing existing data flows at national and subnational level. The system operated without dedicated funding but, despite requiring a large amount of staff time, was sustainable in the medium term without any disruption in the weekly production of updated risk assessment reports.

Continuous communication between the experts at the national institute of health and public health officials across all the regions and autonomous provinces made sure that the assessments reflected what was happening locally each week while supporting the cohesion of the public health network. Also, different data sources and multiple indicators were helpful in maintaining the robustness of the assessment during increased transmission.

The main challenge in conducting the risk assessments during the pandemic was related not to the method’s performance but to difficulties in public communication. While we addressed initial misunderstandings among public health officers through technical discussions, the situation changed when the risk assessments started directly impacting restrictions and, consequently, peoples’ daily lives and livelihoods. Criticism of the risk assessment tool (too complex) or of specific parameters (too delayed) stopped being a technical discussion among subject-matter experts and became a contested topic for decision-makers and the general public.

A similar approach to capturing the components of probability, impact and resilience could be adopted in different countries by adapting existing data flows and deploying available human resources. However, we learnt that to increase the acceptability of risk assessment tools like the one described, robustness in performance is not enough (Box 1). Communication issues in applying risk assessment tools should be anticipated during an emergency. Approaches to resolve these issues need to be designed with communication experts, alongside the development of the risk assessment tools, to ensure that the acceptability of the risk assessments is not damaged by controversies driven by misunderstandings.

Box 1. Summary of main lessons learnt.

  • Decision-making during large-scale disease outbreaks can be supported by robust mixed-method risk assessments informed by public health intelligence and existing surveillance systems without dedicated funding.

  • Continuous communication with health officials across administrative levels ensures that assessments reflect what is happening in the field and supports the cohesion of the public health network during an emergency.

  • Communication issues in applying risk assessment tools should be anticipated during an emergency and approached using dedicated communication tools.

Acknowledgements

The Italian COVID-19 monitoring group consists of Stefania Melena, Michele Labianca, Anna Domenica Mignuoli, Pietro Buono, Maria Giovanna Mattei, Paolo Giorgi Rossi, Fabio Barbone, Francesco Vairo, Paola Scognamiglio, Filippo Ansaldi, Lucia Di Furia, Francesco Sforza, Pier Paolo Benetollo, Pier Paolo Bertoli, Chiara Pasqualini, Lucia Bisceglia, Marcello Tidore, Salvatore Scondotto, Enrica Ricci, Mauro Ruffier, Filippo Da Re, Valentina Marziano, Filippo Trentini, Alessia Rapiti, Stefano Marro, Massimo Fabiani, Maria Fenicia Vescio, Matteo Spuri, Daniele Petrone and Marco Tallon. Flavia Riccardo and Giorgio Guzzetta contributed equally to this publication.

Competing interests:

None declared.

References


Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES